Levetiracetam In Sodium Chloride
Product manufactured by Nexus Pharmaceuticals Inc
Indications and Purposes
1. Indications And Usage Levetiracetam In Sodium Chloride Injection Is Indicated For Adjunct Therapy In Adults (≥16 Years Of Age) With The Following Seizure Types When Oral Administration Is Temporarily Not Feasible: Partial Onset Seizures ( 1.1 ) Myoclonic Seizures In Patients With Juvenile Myoclonic Epilepsy ( 1.2 ) Primary Generalized Tonic-Clonic Seizures ( 1.3 ) 1.1 Partial Onset Seizures Levetiracetam In Sodium Chloride Injection Is Indicated As Adjunctive Therapy In The Treatment Of Partial-Onset Seizures In Adults With Epilepsy. 1.2 Myoclonic Seizures In Patients With Juvenile Myoclonic Epilepsy Levetiracetam In Sodium Chloride Injection Is Indicated As Adjunctive Therapy In The Treatment Of Myoclonic Seizures In Adults With Juvenile Myoclonic Epilepsy. 1.3 Primary Generalized Tonic-Clonic Seizures Levetiracetam In Sodium Chloride Injection Is Indicated As Adjunctive Therapy In The Treatment Of Primary Generalized Tonic-Clonic Seizures In Adults With Idiopathic Generalized Epilepsy. 1.4 Limitations Of Use Levetiracetam In Sodium Chloride Injection Is An Antiepileptic Drug Indicated For Adult Patients (16 Years And Older) When Oral Administration Is Temporarily Not Feasible. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Levetiracetam |
|
ZINC1547851 |